Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1996
08/08/1996CA2212236A1 Bridged indoles as matrix metalloprotease inhibitors
08/08/1996CA2212127A1 Formulations and methods for reducing skin irritation
08/08/1996CA2212061A1 Indole derivatives as 5-ht receptor antagonist
08/08/1996CA2212046A1 Sucralfate preparations
08/08/1996CA2211973A1 Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc
08/08/1996CA2211916A1 New pharmaceutical composition containing trimebutine and preparation process
08/08/1996CA2211783A1 Inhibition of the degradation of connective tissue matrix protein components in mammals
08/08/1996CA2211586A1 Effervescent composition containing iodinated polyvinylpyrrolidone, and use thereof for disinfection___________________________________________
08/08/1996CA2211530A1 Methods of decreasing serum calcium levels
08/08/1996CA2211445A1 Novel medical use of heme products
08/08/1996CA2211189A1 Substituted 1,4-piperazine-heteroaryl derivatives as 5-ht1d receptor agonists
08/08/1996CA2210957A1 The use of carotenoids for producing drugs for the treatment of dermatoses
08/08/1996CA2210746A1 Platelet aggregation inhibitors
08/08/1996CA2210711A1 Transdermal formulation
08/08/1996CA2210093A1 Cyclopropylpyrroloindole-oligopeptide anticancer agents
08/08/1996CA2208603A1 Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
08/08/1996CA2208600A1 2-aminoindans as selective dopamine d3 ligands
08/08/1996CA2186943A1 Methods and apparatus for synthesizing labeled combinatorial chemical libraries
08/07/1996EP0725074A2 Compounds suitable for use as intermediates in the preparation of Androst-3,5-dien-3-carboxy derivatives
08/07/1996EP0725067A1 Substituted biphenyl sulfonamide endothelin antagonists
08/07/1996EP0725064A1 Use of phenylcyclohexylcarboxylic amides
08/07/1996EP0725062A1 4-mercapto-benzoylguanidine derivatives
08/07/1996EP0725061A1 Substituted indole derivatives
08/07/1996EP0724881A1 Method for treating smoking-related bone loss
08/07/1996EP0724880A1 Procedure for encapsulating chlorpheniramine
08/07/1996EP0724879A2 2-Phenyl-3-azoylbenzothiopenes for inhibiting effects of IL-6
08/07/1996EP0724878A2 Use of melatonin for treating patients suffering from drug dependencies
08/07/1996EP0724877A1 Mixture of fenofibrate and vitamin E and its therapeutic use
08/07/1996EP0724648A1 Methods for screening antiestrogen compounds
08/07/1996EP0724647A1 Nucleic acid ligands and improved methods for producing the same
08/07/1996EP0724645A1 Antifungal antibiotic cepacidine a
08/07/1996EP0724594A1 Regulation of transcription factor, nf-il6/lap
08/07/1996EP0724592A1 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors
08/07/1996EP0724591A1 Delta 16 unsaturated c 17 heterocyclic steroids useful as steroid c 17-20 lyase inhibitors
08/07/1996EP0724589A1 A method for enhancing neurone survival and agents useful for same
08/07/1996EP0724587A1 Ring-expanded nucleosides and nucleotides
08/07/1996EP0724586A1 Process for preparing n-(2,6-dichloro-3-methylphenyl)-5-7-dihalo 1,2,4]triazolo 1,5a]pyrimidine-2-sulfonamide by cyclization and halo-dehydroxylation
08/07/1996EP0724584A1 Heterocyclic amines having central nervous system activity
08/07/1996EP0724583A1 Pyridazino quinoline compounds
08/07/1996EP0724582A1 Preparation of omeprazole and lansoprazole and intermediates useful therein
08/07/1996EP0724581A1 Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
08/07/1996EP0724580A1 Benzanilide derivatives as 5ht-1d receptor antagonists
08/07/1996EP0724579A1 Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compounds having retinoid like biological activity
08/07/1996EP0724578A1 Amine derivatives as calcium channel antagonists
08/07/1996EP0724577A1 Heterocyclic amines for treating ischaemic strokes
08/07/1996EP0724573A1 Pyrimidinones as antiarthritic and anti-inflammatories
08/07/1996EP0724572A1 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
08/07/1996EP0724571A1 Substituted pyridine-2-ones and substituted pyridine-2-thiones as biocides
08/07/1996EP0724570A1 Amidino derivatives useful as nitric oxide synthase inhibitors
08/07/1996EP0724567A1 1,11-diesters of prostaglandin-f 2 alpha having a polar ester group at c-1
08/07/1996EP0724566A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation
08/07/1996EP0724565A1 Novel spin trap nitronyl hindered phenols
08/07/1996EP0724561A1 Calcium receptor-active arylalkyl amines
08/07/1996EP0724457A1 Radiation sensitization using texaphyrins
08/07/1996EP0724452A1 PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSPORINE A AND $g(a)-TOCOPHEROL
08/07/1996EP0724450A1 Composition for weight reduction containing ephedrine and a mineral salt or chelate
08/07/1996EP0724448A1 Senna dosage form
08/07/1996EP0724445A1 The use of inositoltrisphosphate for the preparing of medicaments
08/07/1996EP0724443A1 Methods and compositions for lowering intraocular pressure
08/07/1996EP0724442A1 Method for the preparation of quinolone-containing oral compositions
08/07/1996EP0724441A1 Picosulphate dosage form
08/07/1996EP0724440A1 Di- and tetra-hydrobenzo f]quinolin-3-ones
08/07/1996EP0724439A1 Use of 2-(2-alkylphenylamino)-oxazolines, -thiazolines and -imidazolines as alpha 2 adrenergic agents
08/07/1996EP0724438A1 Ibuprofen and flurbiprofen as anti-pruritic agents
08/07/1996EP0724436A1 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces
08/07/1996EP0724435A1 Amidino derivatives useful as nitric oxide synthase inhibitors
08/07/1996EP0724434A1 Multiple unit tableted dosage form containing proton pump inhibitor
08/07/1996EP0724427A1 Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing them
08/07/1996EP0724425A1 New use of prostaglandins
08/07/1996EP0724387A1 Treatment of chronic anti-inflammatory diseases by angiotension ii receptor antagonists
08/07/1996EP0724386A1 Composition and method for treatment of patulous eustachian tube syndrome and atrophic rhinitis
08/07/1996EP0662822A4 Two-phase matrix for sustained release drug delivery device.
08/07/1996EP0661981B1 Use of hyaluronic acid and forms to prevent arterial restenosis
08/07/1996EP0583280B1 Use of torasemide for the treatment of cerebral oedema
08/07/1996EP0576617B1 Composition and method containing optically pure (s) metoprolol
08/07/1996EP0476156B1 Solid oral preparation containing catechol compound
08/07/1996CN1128536A Benzopyrans and pharmaceutical compositions containing them
08/07/1996CN1128531A Therapeutic compound-fatty acid conjugates
08/07/1996CN1128496A Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor
08/07/1996CN1128495A Pharmaceutical compositions for hardly soluble active substances
08/07/1996CN1128269A Oligoribonucleotides with amide backbone
08/07/1996CN1128264A Crystalline form of dihydro-2,3-benzodiazepine derivative
08/07/1996CN1128263A Pyrrolopyrimidine derivatives having pharmacological activity
08/07/1996CN1128262A Substituted biphenyl isoxazole sulfonamides
08/07/1996CN1128261A Process for the preparation of a tetrazole derivative in two crystalline forms and novel crystalline form of said derivative
08/07/1996CN1128260A New piperidine compounds, process for their preparation and the pharmaceutical compositions which contain them
08/07/1996CN1128259A A process for preparing substituted methane-sulphonamide sulphate and solvates thereof
08/07/1996CN1128142A Gepirone dosage form
08/07/1996CN1128141A Duloxetine enteric pellets
08/07/1996CN1032470C Method for processing sulfur-containing heterocyclic compound
08/07/1996CN1032469C Method for processing heterocyclic amide derivant new physical morphogenesis
08/07/1996CA2211521A1 Novel paroxetine hydrochlorine anhydrate forms
08/07/1996CA2168154A1 Substituted biphenyl sulfonamide endothelin antagonists
08/06/1996US5543570 Intermediates for preparing enantiomerically pure imidazo[4,5,1-JK][1,4]-benzodiazepin-2-(1H)-thiones
08/06/1996US5543561 Acyclic amidine group-containing diphosphonic acid derivatives, processes for their preparation and medicaments containing these compounds
08/06/1996US5543556 Esters of acyl l-carnitines with gamma-hydroxybutyric acid and pharmaceutical compositions containing them for inhibiting neuronal degeneration and for the treatment of coma
08/06/1996US5543542 Reacting phosphonosulfonate with oxidizing agent, reacting product with hydroxylamine protecting agent, then with silyl bromide or iodide
08/06/1996US5543530 4-arylisoindole analgesics
08/06/1996US5543528 Useful as angiotensin ii antagonist
08/06/1996US5543527 Process for preparing chiral [[(2-bromoethyl)-amino]methyl]-nitro-1H-imidazol-1-ethanol and related compounds
1 ... 6892 6893 6894 6895 6896 6897 6898 6899 6900 6901 6902 6903 6904 6905 6906 6907 6908 6909 6910 6911 6912 ... 7860